<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chelation for autism spectrum disorder (ASD) - James, S - 2015 | Cochrane Library</title> <meta content="Chelation for autism spectrum disorder (ASD) - James, S - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010766.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chelation for autism spectrum disorder (ASD) - James, S - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010766.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010766.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Chelation for autism spectrum disorder (ASD)" name="citation_title"/> <meta content="Stephen James" name="citation_author"/> <meta content="Southwest Autism Research and Resource Center" name="citation_author_institution"/> <meta content="stephen.james@green.oxon.org" name="citation_author_email"/> <meta content="Shawn W Stevenson" name="citation_author"/> <meta content="University of Melbourne" name="citation_author_institution"/> <meta content="Natalie Silove" name="citation_author"/> <meta content="The Children's Hospital at Westmead" name="citation_author_institution"/> <meta content="Katrina Williams" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD010766.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/05/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010766.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010766.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010766.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Chelation Therapy [adverse effects]; Administration, Oral; Chelating Agents [*administration &amp; dosage, adverse effects]; Child Development Disorders, Pervasive [blood, *therapy]; Glutathione [administration &amp; dosage]; Metals, Heavy [blood]; Randomized Controlled Trials as Topic; Skin Cream [administration &amp; dosage]; Succimer [administration &amp; dosage, adverse effects]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010766.pub2&amp;doi=10.1002/14651858.CD010766.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010766\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010766\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ja","hr","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010766.pub2",title:"Chelation for autism spectrum disorder (ASD)",firstPublishedDate:"May 11, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010766.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010766.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010766.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010766.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010766.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010766.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010766.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010766.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010766.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010766.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7186 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010766.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/appendices#CD010766-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chelation for autism spectrum disorder (ASD)</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#CD010766-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Stephen James</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#CD010766-cr-0003">Shawn W Stevenson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#CD010766-cr-0004">Natalie Silove</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information#CD010766-cr-0005">Katrina Williams</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information/en#CD010766-sec-0116">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 May 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010766.pub2">https://doi.org/10.1002/14651858.CD010766.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010766-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010766-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010766-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010766-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010766-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010766-abs-0002">日本語</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010766-abs-0001" lang="en"> <section id="CD010766-sec-0001"> <h3 class="title" id="CD010766-sec-0001">Background</h3> <p>It has been suggested that the severity of autism spectrum disorder (ASD) symptoms is positively correlated with the level of circulating or stored toxic metals, and that excretion of these heavy metals, brought about by the use of pharmaceutical chelating agents, results in improved symptoms. </p> </section> <section id="CD010766-sec-0002"> <h3 class="title" id="CD010766-sec-0002">Objectives</h3> <p>To assess the potential benefits and adverse effects of pharmaceutical chelating agents (referred to as chelation therapy throughout this review) for autism spectrum disorder (ASD) symptoms. </p> </section> <section id="CD010766-sec-0003"> <h3 class="title" id="CD010766-sec-0003">Search methods</h3> <p>We searched the following databases on 6 November 2014: CENTRAL, Ovid MEDLINE, Ovid MEDLINE In‐Process, Embase, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and 15 other databases, including three trials registers. In addition we checked references lists and contacted experts. </p> </section> <section id="CD010766-sec-0004"> <h3 class="title" id="CD010766-sec-0004">Selection criteria</h3> <p>All randomised controlled trials of pharmaceutical chelating agents compared with placebo in individuals with ASD. </p> </section> <section id="CD010766-sec-0005"> <h3 class="title" id="CD010766-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies, assessed them for risk of bias and extracted relevant data. We did not conduct a meta‐analysis, as only one study was included. </p> </section> <section id="CD010766-sec-0006"> <h3 class="title" id="CD010766-sec-0006">Main results</h3> <p>We excluded nine studies because they were non‐randomised trials or were withdrawn before enrolment. We included one study, which was conducted in two phases. During the first phase of the study, 77 children with ASD were randomly assigned to receive seven days of glutathione lotion or placebo lotion, followed by three days of oral dimercaptosuccinic acid (DMSA). Forty‐nine children who were found to be high excreters of heavy metals during phase one continued on to phase two to receive three days of oral DMSA or placebo followed by 11 days off, with the cycle repeated up to six times. The second phase thus assessed the effectiveness of multiple doses of oral DMSA compared with placebo in children who were high excreters of heavy metals and who received a three‐day course of oral DMSA. Overall, no evidence suggests that multiple rounds of oral DMSA had an effect on ASD symptoms. </p> </section> <section id="CD010766-sec-0007"> <h3 class="title" id="CD010766-sec-0007">Authors' conclusions</h3> <p>This review included data from only one study, which had methodological limitations. As such, no clinical trial evidence was found to suggest that pharmaceutical chelation is an effective intervention for ASD. Given prior reports of serious adverse events, such as hypocalcaemia, renal impairment and reported death, the risks of using chelation for ASD currently outweigh proven benefits. Before further trials are conducted, evidence that supports a causal link between heavy metals and autism and methods that ensure the safety of participants are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010766-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010766-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010766-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010766-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010766-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010766-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010766-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010766-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010766-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010766-abs-0004" lang="en"> <h3>Chelation for autism spectrum disorder (ASD)</h3> <p><b>Background</b> </p> <p>Autism spectrum disorders (ASD) are types of disorders characterised by difficulties in social interaction and communication, and restricted and repetitive behaviours. It has been suggested that increased levels of toxic metals result in more severe symptoms of ASD, and that excretion of these heavy metals brought about by use of pharmaceutical chelating agents (chemicals that are injected into the blood stream to bind to and remove toxic heavy metals from the body) may lead to improvement of symptoms. </p> <p><b>Review question</b> </p> <p>The purpose of this review was to assess the evidence for the effects of pharmaceutical chelating agents for symptoms of ASD. </p> <p><b>Study characteristics</b> </p> <p>We searched multiple databases to find studies that examined pharmaceutical chelating agents as treatment for ASD symptoms. We found only one randomised controlled trial that evaluated oral dimercaptosuccinic acid (DMSA) for ASD, but this trial did not use ideal methods for answering our question. The evidence is current to November 2014. </p> <p>The trial that we found was conducted in two phases. During the first phase, 77 children with ASD were assigned randomly to receive seven days of glutathione lotion or placebo lotion, followed by three days of oral DMSA. Forty‐nine children who excreted high levels of heavy metals during phase one continued on to phase two to receive three days of oral DMSA or placebo followed by 11 days off, with the cycle repeated up to six times. </p> <p><b>Key results</b> </p> <p>Results from the included study show that multiple rounds of oral DMSA did not have an effect on any of the ASD symptoms measured in children found to be high excreters who had already received three doses of a pharmaceutical chelating agent. Currently no clinical trial evidence suggests that pharmaceutical chelation is an effective intervention for ASD. Given prior reports of serious adverse events, such as changes to calcium levels in blood, kidney impairment and reported death, risks of using pharmaceutical chelating agents for ASD currently outweigh proven benefits. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence is poor, with only one study, which had methodological shortcomings, included in this review. These factors, when combined, preclude confidence in the findings. However, before further trials are conducted, more evidence is needed to show that heavy metals cause or worsen the severity of autism, and the safety of pharmaceutical chelating agents for participants must be established. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010766-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010766-sec-0088"></div> <h3 class="title" id="CD010766-sec-0089">Implications for practice</h3> <section id="CD010766-sec-0089"> <p>This review found no high‐quality evidence to suggest that chelation is an effective treatment for improving ASD symptoms. Cochrane reviews typically avoid making recommendations for practice; however, given that harm resulting from the use of chelation therapy has been reported, and that no proven benefits have been found, it seems reasonable to conclude that use of chelation for the treatment of individuals with ASD symptoms should not be recommended. </p> </section> <h3 class="title" id="CD010766-sec-0090">Implications for research</h3> <section id="CD010766-sec-0090"> <p>At the present time, the theory that heavy metals may cause autism or might worsen symptoms has not been established. This underlying theory needs to be tested and confirmed before future trials that assess chelation for ASD symptoms are implemented. However, the numerous side effects of chelation therapy, including hypocalcaemia, renal impairment, musculoskeletal and gastrointestinal symptoms and even death (<a href="./references#CD010766-bbs2-0052" title="MorganBW , KoriS , ThomasJD . Adverse effects in 5 patients receiving EDTA at an outpatient chelation clinic. Veterinary and Human Toxicology2002;44(5):274‐6. ">Morgan 2002</a>; <a href="./references#CD010766-bbs2-0019" title="BrownMJ , WillisT , OmaluB , LeikerR . Deaths resulting from hypocalcemia after administration of edetate disodium: 2003‐2005. Pediatrics2006;118(2):e534‐6. ">Brown 2006</a>; <a href="./references#CD010766-bbs2-0046" title="KosnettMJ . Chelation for heavy metals (arsenic, lead, and mercury): protective or perilous?. Clinical Pharmacology &amp; Therapeutics2010;88(3):412‐5. ">Kosnett 2010</a>), have led to the withdrawal of at least one planned study. It is therefore unlikely that institutional review boards will approve future trials for chelation for ASD unless safety in children can be assured through the current approach to research. </p> <p>If evidence emerges that supports a causal link between heavy metals and autism, further trials with methods suitable to ensure safety and to demonstrate that chelation removes heavy metals, improves social communication and reduces restricted repetitive behaviours seen in autism will be needed. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010766-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010766-sec-0029"></div> <section id="CD010766-sec-0030"> <h3 class="title" id="CD010766-sec-0030">Description of the condition</h3> <p>According to the <i>Diagnostic and Statistical Manual of Mental Disorders</i>, Fifth Edition (DSM‐5), autism spectrum disorder (ASD) is defined as a set of pervasive neurodevelopmental conditions that are characterised by difficulties in social interaction and communication, and by the presence of restricted, repetitive behaviours (i.e. stereotypies) (<a href="./references#CD010766-bbs2-0014" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>). Historically, Asperger’s disorder, autistic disorder, atypical autism and pervasive developmental disorder not otherwise specified (PDD NOS) were considered separate, diagnosable conditions that fall within the autism spectrum. However, the latest edition of the DSM (DSM‐5) (<a href="./references#CD010766-bbs2-0014" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>) has replaced these diagnostic labels with one umbrella term: autism spectrum disorder (ASD). </p> <p>The severity of ASD varies considerably from person to person, and great variability in symptoms and manifestations has been reported. Individuals with ASD have difficulty showing social‐emotional reciprocity (e.g. participating in reciprocal conversations, maintaining eye gaze), communicating verbally and non‐verbally, forming and maintaining relationships and understanding the social behaviour of others (<a href="./references#CD010766-bbs2-0057" title="ShattuckPT , SeltzerMM , GreenbergJS , OrsmondGI , BoltD , KringS , et al. Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder. Journal of Autism and Developmental Disorders2007;37(9):1735‐47. ">Shattuck 2007</a>; <a href="./references#CD010766-bbs2-0014" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>). Individuals with ASD also exhibit preoccupations and restricted, repetitive patterns of interest and behaviours, which may include strong adherence to routines and stereotyped speech and motor movements (<a href="./references#CD010766-bbs2-0047" title="LecavalierL . Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders2006;36(8):1101‐14. ">Lecavalier 2006</a>; <a href="./references#CD010766-bbs2-0014" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>). Some may present with behavioural symptoms (e.g. irritability, aggression, anxiety, self injury, hyperactivity); these features do not determine the diagnosis, rather they are co‐occurring symptoms. Specific causes of ASD are currently unknown. However, genetic factors and prenatal and perhaps postnatal environmental factors are believed to contribute to the onset of ASD, although the role of environmental triggers remains uncertain (<a href="./references#CD010766-bbs2-0038" title="HallmayerJ , ClevelandS , TorresA , PhillipsJ , CohenB , TorigoeT , et al. Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry2011;68(11):1095‐102. ">Hallmayer 2011</a>).  </p> <p>Many interventions are available for ASD, and although some, such as early intensive intervention, are effective in improving communication, social interaction and behaviours, none are capable of producing complete remission of all symptoms. Pharmacological interventions are often prescribed for individuals with ASD, primarily to target specific associated symptoms or co‐occurring features. Currently, however, no pharmacological interventions target the core symptoms of ASD. Individuals with ASD often use complementary and alternative medicine (CAM) too; approximately 75% of children with ASD use CAM (<a href="./references#CD010766-bbs2-0039" title="HansonE , KalishL , BunceE , CurtisC , McDanielS , WareJ , et al. Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism and Developmental Disorders2007;37(4):629‐36. ">Hanson 2007</a>). Examples of CAM used for ASD include exclusion diets, essential fatty acids, multi‐vitamins, acupuncture, auditory integration training and chelation therapy. To date, no consistent evidence indicates that CAM is an effective intervention for the core features and associated behaviours of ASD (<a href="./references#CD010766-bbs2-0053" title="NyeC , BriceA . Combined vitamin B6‐magnesium treatment in autism spectrum disorder. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD003497.pub2] ">Nye 2005</a>; <a href="./references#CD010766-bbs2-0050" title="MillwardC , FerriterM , CalverSJ , Connell‐JonesGG . Gluten‐ and casein‐free diets for autistic spectrum disorder. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD003498.pub3] ">Millward 2008</a>; <a href="./references#CD010766-bbs2-0020" title="CheukDKL , WongV , ChenWX . Acupuncture for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD007849.pub2] ">Cheuk 2011</a>; <a href="./references#CD010766-bbs2-0044" title="JamesS , MontgomeryP , WilliamsK . Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD007992.pub2] ">James 2011</a>; <a href="./references#CD010766-bbs2-0059" title="SinhaY , SiloveN , HayenA , WilliamsK . Auditory integration training and other sound therapies for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD003681.pub3] ">Sinha 2011</a>; <a href="./references#CD010766-bbs2-0032" title="GeretseggerM , ElefantC , MösslerKA , GoldC . Music therapy for people with autism spectrum disorder. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD004381.pub3] ">Geretsegger 2014</a>). </p> </section> <section id="CD010766-sec-0031"> <h3 class="title" id="CD010766-sec-0031">Description of the intervention</h3> <p>Chelation therapy involves administering a chelating substance that binds to heavy metals, such as lead and mercury, which then is excreted in urine. Pharmaceutical chelating substances (referred to as chelation therapy throughout this review) are approved for treating patients with heavy metal poisoning. However, they have also been used for unapproved reasons, including treatment of patients with Alzheimer’s disease, coronary heart disease and ASD (<a href="./references#CD010766-bbs2-0030" title="ErnstE . Chelation therapy for coronary heart disease: an overview of all clinical investigations. American Heart Journal2000;140(1):139‐41. ">Ernst 2000</a>; <a href="./references#CD010766-bbs2-0025" title="DansAL , TanFN , Villarruz‐SulitEC . Chelation therapy for atherosclerotic cardiovascular disease. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD002785] ">Dans 2002</a>; <a href="./references#CD010766-bbs2-0058" title="SinhaY , SiloveN , WilliamsK . Letters. Chelation therapy and autism. BMJ2006;333(7571):756. ">Sinha 2006</a>; <a href="./references#CD010766-bbs2-0040" title="HedgeML , BharathiP , SuramA , VenugopalC , JagannathanR , PoddarP , et al. Challenges associated with metal chelation therapy in Alzheimer's disease. Journal of Alzheimer's Disease2009;17(3):457‐68. ">Hedge 2009</a>). See the section below for theories about the link between autism and heavy metals. Types of pharmaceutical chelating substances used to reduce heavy metal poisoning are outlined in <a href="#CD010766-tbl-0001">Table 1</a>. Chelation therapy is administered for approved uses in a highly controlled environment, which is different from the process followed by practitioners administering chelation for unapproved uses, such as for ASD. </p> <div class="table" id="CD010766-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Examples of chelating agents</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Name</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Target heavy metals</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Route of administration</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> FDA‐approved indications</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Pharmacokinetics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Pharmacodynamics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Common adverse effects</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dimercaptosuccinic acid (DMSA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead; arsenic; mercury poisoning</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead poisoning in adults and children &gt; 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tmax 1 to 2 hours;</p> <p>elimination t<sub>1/2</sub> </p> <p>2 hours to 2 days;</p> <p>primarily excreted renally</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forms water‐soluble chelates with heavy metals, which are excreted renally</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rash; gastrointestinal upset</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edetate disodium (EDTA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calcium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intravenous (IV)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcaemia (emergency treatment);</p> <p>digitalis poisoning; ventricular arrhythmia in adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elimination t<sub>1/2</sub> </p> <p>1.4 to 3 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forms soluble chelate with calcium, resulting in a rapid decrease in plasma calcium concentrations </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue; hypocalcaemia; thrombophlebitis</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sodium 2, 3 dimercaptopropanesulphonate (DMPS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Arsenic; bismuth subcitrate;</p> <p>mercury; Wilson’s disease (copper)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intravenous (IV) and oral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not approved for use in the United States of America</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elimination t<sub>1/2</sub> 1.8 hours </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forms water‐soluble chelates with many heavy metals, which are excreted renally</p> <p>High affinity for mercury</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rash;</p> <p>nausea; dysgeusia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edetate calcium disodium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intravenous (IV) and intramuscular (IM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute and chronic lead poisoning;</p> <p>lead encephalopathy in adults and children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elimination t<sub>1/2</sub> </p> <p>20 to 60 minutes (IV), 1.4 to 3 hours (IM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An effective chelator of extracellular lead, resulting in increased urine excretion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue; nephrotoxicity</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>From <a href="./references#CD010766-bbs2-0054" title="OsterlohJ , BeckerCE . Pharmacokinetics of CaNa2EDTA and chelation of lead in renal failure. Clinical Pharmacology and Therapeutics1986;40(6):686‐93. ">Osterloh 1986</a>; <a href="./references#CD010766-bbs2-0060" title="VamnesJS , EideR , IsrennR , HolPJ , GjerdetNR . Diagnostic value of a chelating agent in patients with symptoms allegedly caused by amalgam fillings. Journal of Dental Research2000;79(3):868‐74. ">Vamnes 2000</a>; <a href="./references#CD010766-bbs2-0028" title="Drugs.com . Drug information online. www.drugs.com/drug‐class/chelating‐agents.html (accessed 10 January 2012). ">Drugs.com 2012</a>. </p> <p>FDA: Food and Drug Administration.<br/> Tmx: time until maximum concentration.<br/> t<sub>1/2</sub>: time until maximum concentration drops in half. </p> </div> </div> <p>Patients with heavy metal poisoning, such as acute lead poisoning, require urgent hospitalisation and administration of chelating substances intravenously or by deep intramuscular injection for four hours. During treatment of patients with acute lead poisoning, blood and urine are monitored constantly, as significant shifts in the heavy metal can occur between the blood and the central nervous system with dire consequences. Moreover, because minerals and metal ions are essential elements that serve important functions in multiple biological processes, excessive removal can lead to deleterious results, for example, a child with ASD recently experienced fatal myocardial necrosis resulting from hypocalcaemia after receiving chelation therapy (<a href="./references#CD010766-bbs2-0019" title="BrownMJ , WillisT , OmaluB , LeikerR . Deaths resulting from hypocalcemia after administration of edetate disodium: 2003‐2005. Pediatrics2006;118(2):e534‐6. ">Brown 2006</a>). </p> <p>Unapproved uses of chelation therapy, for example, when used as an intervention for ASD, may involve practitioners using various chelating substances and unlicensed routes of administration (such as through the rectum or the skin) to remove reported excess levels of mercury, other heavy metals or both (<a href="./references#CD010766-bbs2-0056" title="SempleS , HewtonC , PatersonF , AngleyM . Complementary medicine products used in autism ‐ evidence for efficacy and safety. In: WilliamsT editor(s). Autism Spectrum Disorders ‐ From Genes to Environment. Rijeka, Croatia: InTech, 2011:77‐100. ">Semple 2011</a>). Before treatment, individuals with ASD may undergo preliminary tests with the chelating substance to evoke a response, followed by timed urine collection to determine the levels of heavy metals in the body (<a href="./references#CD010766-bbs2-0018" title="BradstreetJ , GeierDA , KartzinelJJ , AdamsJB , GeierMR . A case‐control study of mercury burden in children with autistic spectrum disorders. Journal of American Physicians and Surgeons2003;8(3):76‐9. ">Bradstreet 2003</a>; <a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>). One of the more commonly used chelating substances, oral dimercaptosuccinic acid (DMSA; also called succimer), is given on a cyclical basis at doses of 10 mg/kg/d every eight hours for three days, followed by 11 days with no DMSA (<a href="./references#CD010766-bbs2-0018" title="BradstreetJ , GeierDA , KartzinelJJ , AdamsJB , GeierMR . A case‐control study of mercury burden in children with autistic spectrum disorders. Journal of American Physicians and Surgeons2003;8(3):76‐9. ">Bradstreet 2003</a>; <a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>). These two‐weekly cycles are repeated up to six times, totalling approximately three months of treatment (<a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>). </p> <p>Between 6% and 11% of families of children with ASD in various English‐speaking countries, including the United States, Canada and Australia, have sought out and tried chelation therapy; most of these families perceived that chelation therapy improved symptoms (<a href="./references#CD010766-bbs2-0037" title="GreenVA , PituchKA , ItchonJ , ChoiA , O'ReillyM , SigafoosJ . Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities2006;27(1):70‐84. ">Green 2006</a>; <a href="./references#CD010766-bbs2-0033" title="Goin‐KochelRP , MackintoshVH , MyersBJ . Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders. Research in Autism Spectrum Disorders2009;3(2):528‐37. ">Goin‐Kochel 2009</a>; <a href="./references#CD010766-bbs2-0021" title="ChristonLM , MackintoshVH , MyersBJ . Use of complementary and alternative medicine (CAM) treatments by parents of children with autism spectrum disorders. Research in Autism Spectrum Disorders2010;4(2):249‐59. ">Christon 2010</a>). </p> </section> <section id="CD010766-sec-0032"> <h3 class="title" id="CD010766-sec-0032">How the intervention might work</h3> <p>The theoretical basis for mercury or other heavy metals as a cause of ASD draws on a wide variety of hypotheses, none yet confirmed. One hypothesis is that mercury or other heavy metals are present in greater quantities in children with ASD, compared with their peers, as a result of intrauterine exposure to maternal stores or intake, increased intake from immunisations (thimerosal), oral ingestion (fish or medication), inhalation (airborne pollution), increased absorption, altered metabolism or decreased excretion (<a href="./references#CD010766-bbs2-0017" title="BernardS , EnayatiA , RedwoodL , RogerH , BinstockT . Autism: a novel form of mercury poisoning. Medical Hypotheses2001;56(4):462‐71. ">Bernard 2001</a>; <a href="./references#CD010766-bbs2-0034" title="GoldmanLR , ShannonMW , American Academy of Pediatrics: Committee on Environmental Health. Technical report: mercury in the environment: implications for pediatricians. Pediatrics2001;108(1):197‐205. ">Goldman 2001</a>; <a href="./references#CD010766-bbs2-0043" title="HolmesAS , BlaxillMF , HaleyBE . Reduced levels of mercury in first baby haircuts of autistic children. International Journal of Toxicology2003;22(4):277‐85. ">Holmes 2003</a>; <a href="./references#CD010766-bbs2-0048" title="LevySE , HymanSL . Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatric Annals2003;32(10):685‐91. ">Levy 2003</a>; <a href="./references#CD010766-bbs2-0024" title="CounterSA , BuchananLH . Mercury exposure in children: a review. Toxicology and Applied Pharmacology2004;198(2):209‐30. ">Counter 2004</a>; <a href="./references#CD010766-bbs2-0045" title="KernJK , GrannemannBD , TrivediMH , AdamsJB . Sulfhydryl‐reactive metals in autism. Journal of Toxicology and Environmental Health, Part A2007;70(8):715‐21. ">Kern 2007</a>). </p> <p>The excess of stored or circulating total body mercury or other heavy metals is thought to interfere with developmental processes implicated in ASD, and it has been suggested that symptoms of mercury poisoning and ASD share some characteristics (<a href="./references#CD010766-bbs2-0017" title="BernardS , EnayatiA , RedwoodL , RogerH , BinstockT . Autism: a novel form of mercury poisoning. Medical Hypotheses2001;56(4):462‐71. ">Bernard 2001</a>). Mercury, through its ability to cross the blood‐brain barrier and the placental barrier, can affect the nervous system and disrupt normal development of the foetus (<a href="./references#CD010766-bbs2-0015" title="AschnerM , AschnerJL . Mercury neurotoxicity: mechanisms of blood‐brain barrier transport. Neuroscience and Biobehavioral Reviews1990;14(2):169‐76. ">Aschner 1990</a>; <a href="./references#CD010766-bbs2-0049" title="LiuJ , GoyerRA , WaalkesMP . Toxic effects of metals. In: KlaassenCD editor(s). Casarett &amp; Doull's Toxicology: The Basic Science of Poisons. 7th Edition. New York: McGraw‐Hill, 2008:931‐79. ">Liu 2008</a>). Prenatal mercury poisoning may result in neurological impairment, global developmental delay and intellectual disability, and postnatal exposure can result in memory loss, irritability, fatigue, intention tremor, skin discolouration and other organ involvement, including kidney dysfunction (e.g. nephrotic syndrome, tubular dysfunction, or both) (<a href="./references#CD010766-bbs2-0016" title="BakirF , DamlujiSF , Amin‐ZakiL , MurtadhaM , KhalidiA , Al‐RawiNY , et al. Methylmercury poisoning in Iraq. Science1973;181(4096):230‐41. ">Bakir 1973</a>; <a href="./references#CD010766-bbs2-0013" title="Amin‐ZakiL , ElhassaniS , MajeedMA , ClarksonTW , DohertyRA , GreenwoodM . Intra‐uterine methylmercury poisoning in Iraq. Pediatrics1974;54(5):587‐95. ">Amin‐Zaki 1974</a>; <a href="./references#CD010766-bbs2-0036" title="GrandjeanP , WeiheP , WhiteRF , DebesF , ArakiS , YokoyamaK , et al. Cognitive deficit in 7‐year‐old children with prenatal exposure to methylmercury. Neurotoxicology and Teratology1997;19(6):417‐28. ">Grandjean 1997</a>; <a href="./references#CD010766-bbs2-0034" title="GoldmanLR , ShannonMW , American Academy of Pediatrics: Committee on Environmental Health. Technical report: mercury in the environment: implications for pediatricians. Pediatrics2001;108(1):197‐205. ">Goldman 2001</a>; <a href="./references#CD010766-bbs2-0024" title="CounterSA , BuchananLH . Mercury exposure in children: a review. Toxicology and Applied Pharmacology2004;198(2):209‐30. ">Counter 2004</a>). </p> <p>Research has produced contradictory findings with regard to levels of heavy metals in individuals with ASD. Three studies (<a href="./references#CD010766-bbs2-0022" title="CohenDJ , JohnsonWT , CaparuloBK . Pica and elevated blood lead level in autistic and atypical children. American Journal of Diseases of Children1976;130(1):47‐8. ">Cohen 1976</a>; <a href="./references#CD010766-bbs2-0023" title="CohenDJ , PaulR , AndersonGM , HarcherikDF . Blood lead in autistic children. Lancet1982;320(8289):94‐5. ">Cohen 1982</a>; <a href="./references#CD010766-bbs2-0011" title="AdamsJB , AudhyaT , McDonough‐MeansS , RubinRA , QuigD , GeisE , et al. Toxicological status of children with autism vs. neurotypical children and the association with autism severity. Biological Trace Element Research2013;151(2):171‐80. ">Adams 2013</a>) (N = 34, N = 93 and N = 99, respectively), all from the USA, found higher levels of lead in individuals with ASD compared with individuals without ASD, with overlapping levels observed between diagnostic groups. One of these studies also reported elevated levels of heavy metals (lead, thallium and tungsten) in urine (<a href="./references#CD010766-bbs2-0011" title="AdamsJB , AudhyaT , McDonough‐MeansS , RubinRA , QuigD , GeisE , et al. Toxicological status of children with autism vs. neurotypical children and the association with autism severity. Biological Trace Element Research2013;151(2):171‐80. ">Adams 2013</a>). Two studies ‐ one from the USA (N = 452) and one from Jamaica (N = 130) ‐ exploring differences in mercury level in blood reported no association between ASD and higher levels of mercury when analyses were adjusted for fish eating and other relevant factors (<a href="./references#CD010766-bbs2-0041" title="Hertz‐PicciottoI , GreenPG , DelwicheL , HansenR , WalkerC , PessahLN . Blood mercury concentrations in CHARGE study children with and without autism. Environmental Health Perspectives2010;118(1):161‐6. ">Hertz‐Picciotto 2010</a>; <a href="./references#CD010766-bbs2-0055" title="RahbarMH , Samms‐VaughanM , LovelandKA , Ardjomand‐HessabiM , ChenZ , BresslerJ , et al. Seafood consumption and blood and blood mercury concentrations in Jamaican children with and without autism spectrum disorders. Neurotoxicity Research2013;23(1):22‐38. ">Rahbar 2013</a>). Another smaller study from Italy (N = 37) found no difference in mercury, or in other heavy metals, between individuals with ASD and a group recruited from a neuropsychiatric service who did not have ASD (<a href="./references#CD010766-bbs2-0012" title="AlbizzatiA , MoreL , DiCandiaD , SaccaniM , LentiC . Normal concentrations of heavy metals in autistic spectrum disorders. Minerva Pediatrica2012;64(1):27‐31. ">Albizzati 2012</a>). </p> <p>An alternative hypothesis is that mercury or other heavy metals can cause ASD through altered cellular functioning, which does not require increased body stores or circulating mercury or other heavy metals. In this context, it is thought that individuals with ASD have an impaired capacity to excrete heavy metals, and that the severity of autism symptoms is inversely correlated with excretion ability (<a href="./references#CD010766-bbs2-0043" title="HolmesAS , BlaxillMF , HaleyBE . Reduced levels of mercury in first baby haircuts of autistic children. International Journal of Toxicology2003;22(4):277‐85. ">Holmes 2003</a>; <a href="./references#CD010766-bbs2-0045" title="KernJK , GrannemannBD , TrivediMH , AdamsJB . Sulfhydryl‐reactive metals in autism. Journal of Toxicology and Environmental Health, Part A2007;70(8):715‐21. ">Kern 2007</a>). This hypothesis is currently being explored (<a href="./references#CD010766-bbs2-0027" title="DethR , MuratoreC , BenzecryJ , Power‐CharnitskyV , WalyM . How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicology2008;29(1):190‐201. ">Deth 2008</a>; <a href="./references#CD010766-bbs2-0061" title="ZecavatiN , SpenceSJ . Neurometabolic disorders and dysfunction in autism spectrum disorders. Current Neurology and Neuroscience Reports2009;9(2):129‐36. ">Zecavati 2009</a>; <a href="./references#CD010766-bbs2-0031" title="GarrechtM , AustinDW . The plausibility of a role for mercury in the etiology of autism: a cellular perspective. Toxicological and Environmental Chemistry2011;93(5‐6):1251‐73. ">Garrecht 2011</a>). </p> </section> <section id="CD010766-sec-0033"> <h3 class="title" id="CD010766-sec-0033">Why it is important to do this review</h3> <p>Novel therapies are used frequently by individuals with ASD (<a href="./references#CD010766-bbs2-0039" title="HansonE , KalishL , BunceE , CurtisC , McDanielS , WareJ , et al. Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism and Developmental Disorders2007;37(4):629‐36. ">Hanson 2007</a>). Despite their increasing use, most types of CAM for ASD lack a robust evidence base (<a href="./references#CD010766-bbs2-0053" title="NyeC , BriceA . Combined vitamin B6‐magnesium treatment in autism spectrum disorder. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD003497.pub2] ">Nye 2005</a>; <a href="./references#CD010766-bbs2-0050" title="MillwardC , FerriterM , CalverSJ , Connell‐JonesGG . Gluten‐ and casein‐free diets for autistic spectrum disorder. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD003498.pub3] ">Millward 2008</a>; <a href="./references#CD010766-bbs2-0020" title="CheukDKL , WongV , ChenWX . Acupuncture for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD007849.pub2] ">Cheuk 2011</a>; <a href="./references#CD010766-bbs2-0044" title="JamesS , MontgomeryP , WilliamsK . Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD007992.pub2] ">James 2011</a>; <a href="./references#CD010766-bbs2-0059" title="SinhaY , SiloveN , HayenA , WilliamsK . Auditory integration training and other sound therapies for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD003681.pub3] ">Sinha 2011</a>; <a href="./references#CD010766-bbs2-0032" title="GeretseggerM , ElefantC , MösslerKA , GoldC . Music therapy for people with autism spectrum disorder. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD004381.pub3] ">Geretsegger 2014</a>). Chelation therapy is one CAM that continues to be used and promoted as efficacious, despite reports of harm, withdrawal of a trial before recruitment because of safety concerns (<a href="./references#CD010766-bbs2-0051" title="MitkaM . Chelation therapy trials halted. JAMA2008;300(19):2236. ">Mitka 2008</a>) and discouragement by physicians (<a href="./references#CD010766-bbs2-0035" title="GolnikAE , IrelandM . Complementary alternative medicine for children with autism: a physician survey. Journal of Autism and Developmental Disorders2009;39(7):996‐1005. ">Golnik 2009</a>). Adverse effects commonly reported with the use of pharmaceutical chelating agents are listed in <a href="#CD010766-tbl-0001">Table 1</a>. Deaths have also been reported (<a href="https://archie.cochrane.org/sections/documents/view?document=77585545145350558129120125135642%26format=REVMAN#REF-Brown-2006" target="_blank">Brown 2006</a>). A systematic review that examines potential beneficial and harmful effects of chelation for symptoms of ASD is urgently needed. Results from this systematic review will help families with ASD make well‐informed decisions about the use of chelation therapy and will assist relevant services and guide other organisations in making decisions about best practice. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010766-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010766-sec-0034"></div> <p>To assess the potential benefits and adverse effects of pharmaceutical chelating agents (referred to as chelation therapy throughout this review) for autism spectrum disorder (ASD) symptoms. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010766-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010766-sec-0035"></div> <section id="CD010766-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010766-sec-0037"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials.</p> </section> <section id="CD010766-sec-0038"> <h4 class="title">Types of participants</h4> <p>Individuals of any age diagnosed with ASD using established diagnostic criteria (e.g. <i>Diagnostic and Statistical Manual of Mental Disorders</i>, Fourth Edition (DSM‐IV)) or standardised diagnostic instruments (e.g. the Childhood Autism Rating Scale (CARS), the Autism Diagnostic Observation Scale (ADOS), the Autism Diagnostic Interview ‐ Revised (ADI‐R)) were eligible for inclusion in this review. </p> </section> <section id="CD010766-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Interventions were eligible for inclusion if they involved chelating substances of any type and dose, regardless of administration frequency or method, compared with placebo. Trials were also eligible for inclusion if the chelating substances were provided alone or as adjunctive treatment compared with placebo (e.g. chelation in combination with a behavioural intervention vs placebo in combination with a behavioural intervention). </p> </section> <section id="CD010766-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD010766-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010766-list-0001"> <li> <p>Changes in the following core symptoms of ASD, using any measure (e.g. the Aberrant Behavior Checklist (ABC), CARS), as assessed separately. </p> <ol id="CD010766-list-0002"> <li> <p>Social interaction.</p> </li> <li> <p>Communication.</p> </li> <li> <p>Stereotypy.</p> </li> </ol> </li> <li> <p>Adverse events.</p> </li> </ol> </p> </section> <section id="CD010766-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010766-list-0003"> <li> <p>Changes in the following non‐core behaviours, using any measure (e.g. ABC, CARS), as assessed separately. </p> <ol id="CD010766-list-0004"> <li> <p>Irritability.</p> </li> <li> <p>Aggression.</p> </li> <li> <p>Hyperactivity.</p> </li> <li> <p>Insomnia.</p> </li> <li> <p>Self injury.</p> </li> </ol> </li> <li> <p>Quality of life for individual or family.</p> </li> <li> <p>Heavy metal levels in blood or non‐provoked urine. Provoked urine will be examined cautiously (as provocation testing elevates urine heavy metal levels). </p> </li> </ol> </p> </section> </section> </section> <section id="CD010766-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <p>We first searched databases for this review in December 2013 and repeated the searches, beginning on 6 November 2014, to find new studies published in the intervening period. </p> <section id="CD010766-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases with no language or date restrictions.</p> <p> <ol id="CD010766-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) 2014, Issue 11, part of the <i>Cochrane Library.</i> </p> </li> <li> <p>Ovid MEDLINE, 1946 to October Week 5 2014.</p> </li> <li> <p>Ovid MEDLINE In‐Process and Other Non‐indexed Citations, 5 November 2014.</p> </li> <li> <p>Embase (Ovid), 1980 to Week 44.</p> </li> <li> <p>PsycINFO (Ovid), 1967 to November Week 1 2014.</p> </li> <li> <p>Science Citation Index (Web of Science), 1970 to 5 November 2014.</p> </li> <li> <p>Social Sciences Citation Index (Web of Science), 1970 to 5 November 2014.</p> </li> <li> <p>Conference Proceedings Citation Index – Science (Web of Science), 1990 to 5 November 2014. </p> </li> <li> <p>Conference Proceedings Citation Index – Social Science &amp; Humanities (Web of Science), 1990 to 5 November 2014. </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE) 2014, Issue 4, part of the <i>Cochrane Library.</i> </p> </li> <li> <p>Cochrane Database of Systematic Reviews (CDSR) 2014, Issue 11, part of the <i>Cochrane Library.</i> </p> </li> <li> <p>Heatlh Technology Assessment Database 2014, Issue 4, part of the <i>Cochrane Library.</i> </p> </li> <li> <p>CINAHL Plus (Cumulative Index to Nursing and Allied Health Literature) (EBSCOhost), 1937 to current. </p> </li> <li> <p>Autism Data (<a href="http://www.autism.org.uk/autismdata" target="_blank">www.autism.org.uk/autismdata</a>). </p> </li> <li> <p>WorldCat (limited to theses and dissertations) (<a href="http://www.worldcat.org/" target="_blank">www.worldcat.org/)</a>). </p> </li> <li> <p>metaRegister of Controlled Trials (mRCT) (<a href="http://www.controlled-trials.com/mrct/search.html" target="_blank">www.controlled‐trials.com/mrct/search.html</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>). </p> </li> <li> <p>International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> </li> <li> <p>TOXNET (<a href="http://toxnet.nlm.nih.gov/" target="_blank">toxnet.nlm.nih.gov/</a>). </p> </li> <li> <p>Latin American Caribbean Health Sciences Literature (LILACS) (<a href="http://search.bvsalud.org/portal/advanced/?lang=en" target="_blank">search.bvsalud.org/portal/advanced/?lang=en</a>). </p> </li> <li> <p>Scientific Electronic Library Online (SciELO) (<a href="http://www.scielo.br/cgi-bin/wxis.exe/iah/" target="_blank">scielo.br/cgi‐bin/wxis.exe/iah/</a>). </p> </li> <li> <p>Google Scholar (<a href="https://scholar.google.com/" target="_blank">scholar.google.com/</a>). </p> </li> </ol> </p> <p>We reported the searches in detail in <a href="./appendices#CD010766-sec-0093">Appendix 1</a>. </p> </section> <section id="CD010766-sec-0045"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists from the retrieved articles for studies not already identified, and we contacted known experts in the field to enquire about other sources of information. We also searched relevant websites, including Autism Speaks (<a href="http://www.autismspeaks.org/" target="_blank">www.autismspeaks.org/</a>), Research Autism (<a href="http://researchautism.net/" target="_blank">http://researchautism.net/</a>) and the US Department of Health and Human Services (<a href="http://www.hhs.gov/" target="_blank">www.hhs.gov/</a>). </p> </section> </section> <section id="CD010766-sec-0046"> <h3 class="title" id="CD010766-sec-0046">Data collection and analysis</h3> <section id="CD010766-sec-0047"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SJ and SS) independently screened the titles and abstracts of citations identified by the search. SJ and SS then obtained and reviewed the full text of studies that met, or seemed likely to meet, the inclusion criteria. In the event of uncertainties and differences of opinion, resolution was reached through discussions with the third and fourth review authors (NS and KW). </p> </section> <section id="CD010766-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SJ and SS) independently extracted the following information from the included study using a data extraction form designed and piloted for this review. </p> <p> <ol id="CD010766-list-0006"> <li> <p>Study methods and setting, including study duration, design and location.</p> </li> <li> <p>Participant details, including age, gender, sample size and diagnosis.</p> </li> <li> <p>Intervention details.</p> </li> <li> <p>Outcomes.</p> </li> </ol> </p> <p>No disagreements arose.</p> </section> <section id="CD010766-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SJ and SS) independently assessed risk of bias of the included study using the tool described in the <i>Cochrane Handbook of Systematic Reviews of Interventions</i> (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>, section 8.5.a). For the included study, we judged the risk of bias to be low, high or unclear for each of the following domains. </p> <p> <ol id="CD010766-list-0007"> <li> <p>Sequence generation.</p> <ol id="CD010766-list-0008"> <li> <p>Low risk: if a random component was used in the sequence generation process, such as coin‐tossing, computer‐generated random numbers or a table of random numbers. </p> </li> <li> <p>High risk: if a non‐random component was used in the sequence generation process.</p> </li> <li> <p>Unclear risk: if the sequence generation process was not described.</p> </li> </ol> </li> <li> <p>Allocation concealment.</p> <ol id="CD010766-list-0009"> <li> <p>Low risk: if participants and trial investigators had no foreknowledge (i.e. before eligibility, decisions made and informed consent obtained) of intervention assignment through the use of, for example, central allocation or sequentially numbered envelopes that were opaque and sealed. </p> </li> <li> <p>High risk: if participants and trial investigators had foreknowledge of intervention assignment. </p> </li> <li> <p>Unclear risk: if the method of allocation concealment was not described.</p> </li> </ol> </li> <li> <p>Blinding of participants and personnel.</p> <ol id="CD010766-list-0010"> <li> <p>Low risk: if no blinding or incomplete blinding was reported but review authors judged the outcome as unlikely to have been influenced by lack of blinding, or if blinding of study participants and personnel was ensured and it is unlikely that blinding could have been broken. </p> </li> <li> <p>High risk: if no blinding or incomplete blinding was reported and the outcome was likely influenced by lack of blinding, or if blinding of study participants and personnel was attempted but it is likely that blinding could have been broken and the outcome influenced by lack of blinding. </p> </li> <li> <p>Unclear risk: if lack of information prohibits judgement of low or high risk of bias, or if the study did not address this outcome. </p> </li> </ol> </li> <li> <p>Blinding of outcome assessment.</p> <ol id="CD010766-list-0011"> <li> <p>Low risk: if no blinding of outcome assessment was reported but review authors judged the outcome measurement as unlikely to have been influenced by lack of blinding, or if blinding of outcome assessment was ensured and it is unlikely that blinding could have been broken. </p> </li> <li> <p>High risk: if no blinding of outcome assessment was reported and the outcome measurement was likely influenced by lack of blinding, or if blinding of outcome assessment was reported but it is likely that blinding could have been broken and the outcome measurement influenced by lack of blinding. </p> </li> <li> <p>Unclear risk: if lack of information prohibits judgement of low or high risk of bias, or if the study did not address this outcome. </p> </li> </ol> </li> <li> <p>Incomplete outcome data.</p> <ol id="CD010766-list-0012"> <li> <p>Low risk: if no missing data were reported or if appropriate methods were used to impute missing data, or if the reason for missing data is unlikely to be related to the true outcome. </p> </li> <li> <p>High risk: if missing data were reported and no appropriate methods were used to impute missing data, or if the reason for missing data is likely to be related to the true outcome. </p> </li> <li> <p>Unclear risk: if lack of information prohibits judgement of low or high risk of bias, or if the study did not address this outcome. </p> </li> </ol> </li> <li> <p>Selective reporting.</p> <ol id="CD010766-list-0013"> <li> <p>Low risk: if a study has a protocol and all prespecified outcomes were reported in the prespecified manner, or if a study has no protocol but all expected outcomes have been reported. </p> </li> <li> <p>High risk: if a study has a protocol and one or more prespecified outcomes were not reported or were reported in a manner that was not prespecified, or if a study has no protocol and all expected outcomes have not been reported. </p> </li> <li> <p>Unclear risk: if lack of information prohibits judgement of low or high risk of bias.</p> </li> </ol> </li> <li> <p>Other bias.</p> <ol id="CD010766-list-0014"> <li> <p>Low risk: if other sources of bias (e.g. contamination, recruitment bias) do not appear to exist. </p> </li> <li> <p>High risk: if other sources of bias exist.</p> </li> <li> <p>Unclear risk: if lack of information permits judgement of whether other sources of bias exist. </p> </li> </ol> </li> </ol> </p> <p>No differences of opinions arose.</p> </section> <section id="CD010766-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We did not conduct a meta‐analysis, given that only one study was included in this review. Analysis methods that we will use in updates of this review can be found in <a href="#CD010766-tbl-0002">Table 2</a> and in our protocol (<a href="./references#CD010766-bbs2-0062" title="JamesS , WilliamsK , SiloveN , StevensonSW . Chelation for autism spectrum disorder (ASD). Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD010766] ">James 2013</a>). </p> <div class="table" id="CD010766-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Analysis methods planned in our protocol that will be used in updates of this review</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of treatment effect</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will analyse dichotomous outcomes by calculating the risk ratio (RR) and the corresponding 95% confidence interval (CI). For continuous data, we will calculate mean difference (MD) and corresponding 95% CI if studies used the same rating scales. As recommended by <a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>, we will focus on final values unless change scores are used in some of the studies. We will combine in the same meta‐analysis studies that reported final values with studies that reported only change scores, provided the studies used the same rating scale (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). A potential problem associated with including change scores is that the standard deviation of changes may not be reported in the original study (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We will contact trial authors and will attempt to estimate the standard deviation of changes if not reported. We will calculate the standardised mean difference (SMD) with 95% CIs if studies used different scales to measure the same outcomes </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Multiple outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If studies provided multiple, interchangeable measures of the same construct at the same point in time, we will calculate the average SMD across outcomes and the average estimated variances (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis issues</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>When possible, we will obtain mean treatment differences and standard errors for cross‐over trials, and will enter these into RevMan under the generic inverse variance outcome type (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We will create a single pair‐wise comparison for each identified multi‐arm study by combining all relevant experimental groups into a single group, and by combining all relevant control groups into a single group (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dealing with missing data</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will attempt to contact trial investigators to request missing data. If missing data are provided by the trialists, we will conduct meta‐analysis according to intention‐to‐treat principles using all data and keeping participants in the treatment group to which they were originally randomly assigned, regardless of the treatment that they actually received (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If missing data are not provided, we will analyse only available data, and we will not impute missing data given that symptoms of autism spectrum disorder (ASD) vary greatly. We will document missing data and attrition in the ’Risk of bias’ table, and we will discuss how missing data may affect interpretation of the results </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of heterogeneity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will assess clinical heterogeneity by comparing the between‐trials distribution of participant characteristics (e.g. children vs adults), trial characteristics (e.g. cross‐over vs parallel design) and intervention characteristics (e.g. treatment type, dose). We will evaluate statistical heterogeneity using the I² statistic and the Chi² test of heterogeneity, with statistical significance set at P value &lt; 0.10. We will consider I² values as follows. </p> <p> <ol id="CD010766-list-0015"> <li> <p>0% to 29% might not be important</p> </li> <li> <p>30% to 49% may represent moderate heterogeneity</p> </li> <li> <p>50% to 74% may represent substantial heterogeneity</p> </li> <li> <p>75% to 100% represents considerable heterogeneity (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of reporting biases</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If 10 or more studies are found, we will use funnel plots to investigate the relationship between intervention effect and study size. Asymmetry of a funnel plot may indicate, among other things, publication bias or poor methodological quality (<a href="./references#CD010766-bbs2-0029" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). We will explore possible reasons for any asymmetry found </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Data synthesis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will synthesise results in a meta‐analysis using a fixed‐effect model when studies are similar enough with regard to the intervention, population and methods to assume that the same treatment effect is estimated. We will synthesise results in a meta‐analysis using a random‐effects model when statistical heterogeneity is found, or when studies differ enough with regard to the intervention, population and methods to assume that different yet related treatment effects are estimated, and when it is deemed to be clinically relevant (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct the following subgroup analyses</p> <p> <ol id="CD010766-list-0016"> <li> <p>Type of ASD (e.g. autistic disorder vs Asperger’s disorder)</p> </li> <li> <p>Participant age (e.g. adult vs child, preschool vs school‐age)</p> </li> <li> <p>Treatment type (e.g. dimercaptosuccinic acid (DMSA) vs other agents)</p> </li> <li> <p>Treatment dosage (e.g. DMSA dose of 10 mg/kg body weight administered 3 times per day vs higher doses) </p> </li> <li> <p>Length of follow‐up (e.g. ≤ 3 months vs &gt; 3 months)</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct sensitivity analyses to investigate the effect on overall results of excluding trials when </p> <p> <ol id="CD010766-list-0017"> <li> <p>Allocation concealment or sequence generation was inadequate (selection bias)</p> </li> <li> <p>Blinding was not done (performance bias)</p> </li> <li> <p>Outcome data were incomplete (attrition bias)</p> </li> </ol> </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010766-sec-0051"> <h4 class="title">Dealing with missing data</h4> <p>We assessed and reported missing data and dropouts for the included study (see <a href="./references#CD010766-sec-0121" title="">Characteristics of included studies</a>). Based on our judgement that missing data and dropouts in the included study were unlikely related to the outcomes (and missing data appeared balanced across intervention groups, with similar reasons for missing data across groups), we did not contact the trial investigators for further information. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010766-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010766-sec-0052"></div> <section id="CD010766-sec-0053"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD010766-sec-0121" title="">Characteristics of included studies</a> and <a href="./references#CD010766-sec-0122" title="">Characteristics of excluded studies</a>. </p> <section id="CD010766-sec-0054"> <h4 class="title">Results of the search</h4> <p>Our search strategy identified 846 citations, of which 12 were deemed to be potentially eligible on the basis of title or abstract (see <a href="#CD010766-fig-0001">Figure 1</a>). We obtained full‐text copies of these 12 reports and inspected them. After all full‐text copies had been reviewed, we included three reports of one study (<a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>) and excluded nine reports (<a href="./references#CD010766-bbs2-0003" title="EpprightTD , SanfaconJA , HorwitzEA . Attention deficit hyperactivity disorder, infantile autism, and elevated blood‐lead: a possible relationship. Missouri Medicine1996;93(3):136‐8. ">Eppright 1996</a>; <a href="./references#CD010766-bbs2-0007" title="LonsdaleD , ShambergerRJ , AudhyaT . Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinology Letters2002;23(4):303‐8. ">Lonsdale 2002</a>; <a href="./references#CD010766-bbs2-0004" title="GeierDA , GeierMR . A clinical trial of combined anti‐androgen and anti‐heavy metal therapy in autistic disorders. Neuro Endocrinology Letters2006;27(6):833‐8. ">Geier 2006a</a>; <a href="./references#CD010766-bbs2-0005" title="GeierDA , GeierMR . A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotoxicity Research2006;10(1):57‐64. ">Geier 2006b</a>; <a href="./references#CD010766-bbs2-0008" title="NatafR , SkorupkaC , AmetL , LamA , SpringbettA , LatheR . Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicology and Applied Pharmacology2006;214(2):99‐108. ">Nataf 2006</a>; <a href="./references#CD010766-bbs2-0006" title="GeierDA , GeierMR . A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. Journal of Toxicology and Environmental Health, Part A2007;70(20):1723‐30. ">Geier 2007</a>; <a href="./references#CD010766-bbs2-0010" title="PatelK , CurtisLT . A comprehensive approach to treating autism and attention‐deficit hyperactivity disorder: a prepilot study. Journal of Alternative and Complementary Medicine2007;13(10):1091‐7. ">Patel 2007</a>; <a href="./references#CD010766-bbs2-0002" title="Blaucok‐BuschE , AminOR , DessokiHH , RabahT . Efficacy of DMSA therapy in a sample of Arab children with autistic spectrum disorder. Maedica2012;7(3):214‐21. ">Blaucok‐Busch 2012</a>; <a href="./references#CD010766-bbs2-0009" title="NCT00376194 . Mercury chelation to treat autism. http://clinicaltrials.gov/show/NCT00376194 (accessed 19 December 2013). ">NCT00376194</a>). </p> <div class="figure" id="CD010766-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010766-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_n/nCD010766-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010766-sec-0055"> <h4 class="title">Included studies</h4> <p>The study included in this review was reported to be randomised and double‐blind (<a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>). Although it fulfilled criteria for inclusion, the methods, which we have outlined here, are not appropriate to allow testing of the hypothesis of interest in this review. Instead, the included study was conducted in two phases: During the first phase, participants were randomly assigned to receive seven days of glutathione lotion (experimental group) or placebo lotion (control group) followed by three days of oral dimercaptosuccinic acid (DMSA) (for all children). This phase tested whether topical glutathione was absorbed and whether topical glutathione was effective for increasing the effectiveness of oral DMSA. During the second phase, a subset of participants ‐ high heavy metal excreters ‐ from phase one were randomly assigned to receive three days of oral DMSA (experimental group) or placebo (control group) followed by 11 days off, with this cycle repeated up to six times. This phase assessed the effectiveness of multiple doses of oral DMSA compared with placebo in children who were high excreters of heavy metals and who had received a three‐day course of oral DMSA. </p> <p>We discussed at length whether the study should be included, as all children entering phase two had already received a chelating agent. Ultimately, however, we believed that we would not be deviating from protocol by including the study, because the second phase of the study was a randomised placebo‐controlled trial. </p> <section id="CD010766-sec-0056"> <h5 class="title">Participants</h5> <p>A total of 82 children, aged three to eight years, enrolled in the included study, of whom 77 completed the required initial blood collection (to assess baseline liver and kidney function, red blood cell (RBC) glutathione, and complete blood count (CBC)). Although the total number of children randomly assigned (and the number randomly assigned to each group) is not explicitly stated, it appears as though randomisation occurred after the initial blood collection (i.e. for the 77 children). All children (69 male and eight female; mean age 6.3 years) were Arizona residents who had been diagnosed with autism spectrum disorder (autism 95%, pervasive developmental disorder not otherwise specified (PDD NOS) 3%, Asperger's 3%) by a psychiatrist, a psychologist or a developmental paediatrician. Only 65 participants completed phase one, and 49 heavy metal excreting participants were included in phase two. </p> </section> <section id="CD010766-sec-0057"> <h5 class="title">Interventions</h5> <p>For the first phase of the included study, children in the experimental group initially received glutathione lotion, which was administered once per day for seven days. Each daily dosage contained ˜ 180 mg of “reduced 1‐glutathione in a lotion of isopropyl myristate, mineral oil, caprylic/capric triglyceride, and vitamin E acetate” (<a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>, p 5). Children in the control group received a placebo lotion that was identical in packaging and contained a similar formulation (with the exception of glutathione). After receiving the glutathione or placebo lotion for seven days, all children received one round of oral DMSA, administered in a 10 mg/kg dose, three times per day for three days. All children were given one round of oral DMSA for screening purposes to ensure that only high heavy metal excreters continued on to the second phase. </p> <p>For the second phase of the included study, all children had received a three‐day course of oral DMSA before randomisation. The experimental group received up to six more rounds of oral DMSA. Each round consisted of a 10 mg/kg dose, administered three times per day for three days, followed by 11 days of no DMSA. Children in the control group received up to six rounds of placebo (methyl cellulose), which was similar to DMSA in appearance and was packaged in identical bottles. Each round consisted of three days on placebo, followed by 11 days off. </p> </section> <section id="CD010766-sec-0058"> <h5 class="title">Outcomes</h5> <p>Blood was collected to assess CBC and RBC glutathione. Blood was collected at the beginning of phase one, at the beginning of phase two, after the third round of oral DMSA/placebo in phase two and after the sixth round of oral DMSA/placebo in phase two. Urine was collected to assess excretion of toxic metals and essential minerals. Urine was collected at the beginning of phase one, after the first dose of oral DMSA in phase one, after the ninth dose in phase one and at the end of the second round in phase two. Severity of autism symptoms was assessed using the Pervasive Developmental Disorder Behavior Inventory (PDD‐BI), the Autism Treatment Evaluation Checklist (ATEC), the Severity of Autism Scale (SAS) and the Autism Diagnostic Observation Schedule (ADOS). The ATEC was administered at the beginning of phase one and at the end of phase two. The PDD‐BI, SAS and ADOS were administered at the beginning of phase two and at the end of phase two. Changes in autism symptoms were assessed at the end of phase two using the Parental Global Impressions (PGI) questionnaire. </p> <p>As such, the included trial was able to answer only the following question.</p> <p>Do repeated doses of oral DMSA decrease core features of ASD in children who have previously received a three‐day course of oral DMSA and are known to be high excreters? </p> <p>Only outcomes that were available at the beginning of phase one and at the completion of phase two, or were available at the beginning and end of phase two, could assist with answering this question. </p> <p>See also the <a href="./references#CD010766-sec-0121" title="">Characteristics of included studies</a> table. </p> </section> </section> <section id="CD010766-sec-0059"> <h4 class="title">Excluded studies</h4> <p>We excluded nine studies ‐ eight studies because they were non‐randomised (<a href="./references#CD010766-bbs2-0003" title="EpprightTD , SanfaconJA , HorwitzEA . Attention deficit hyperactivity disorder, infantile autism, and elevated blood‐lead: a possible relationship. Missouri Medicine1996;93(3):136‐8. ">Eppright 1996</a>; <a href="./references#CD010766-bbs2-0007" title="LonsdaleD , ShambergerRJ , AudhyaT . Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinology Letters2002;23(4):303‐8. ">Lonsdale 2002</a>; <a href="./references#CD010766-bbs2-0004" title="GeierDA , GeierMR . A clinical trial of combined anti‐androgen and anti‐heavy metal therapy in autistic disorders. Neuro Endocrinology Letters2006;27(6):833‐8. ">Geier 2006a</a>; <a href="./references#CD010766-bbs2-0005" title="GeierDA , GeierMR . A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotoxicity Research2006;10(1):57‐64. ">Geier 2006b</a>; <a href="./references#CD010766-bbs2-0008" title="NatafR , SkorupkaC , AmetL , LamA , SpringbettA , LatheR . Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicology and Applied Pharmacology2006;214(2):99‐108. ">Nataf 2006</a>; <a href="./references#CD010766-bbs2-0006" title="GeierDA , GeierMR . A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. Journal of Toxicology and Environmental Health, Part A2007;70(20):1723‐30. ">Geier 2007</a>; <a href="./references#CD010766-bbs2-0010" title="PatelK , CurtisLT . A comprehensive approach to treating autism and attention‐deficit hyperactivity disorder: a prepilot study. Journal of Alternative and Complementary Medicine2007;13(10):1091‐7. ">Patel 2007</a>; <a href="./references#CD010766-bbs2-0002" title="Blaucok‐BuschE , AminOR , DessokiHH , RabahT . Efficacy of DMSA therapy in a sample of Arab children with autistic spectrum disorder. Maedica2012;7(3):214‐21. ">Blaucok‐Busch 2012</a>) and one study because it was withdrawn before enrolment (<a href="./references#CD010766-bbs2-0009" title="NCT00376194 . Mercury chelation to treat autism. http://clinicaltrials.gov/show/NCT00376194 (accessed 19 December 2013). ">NCT00376194</a>). See the <a href="./references#CD010766-sec-0122" title="">Characteristics of excluded studies</a> table for more information. </p> </section> </section> <section id="CD010766-sec-0060"> <h3 class="title">Risk of bias in included studies</h3> <p>An overview of risk of bias is illustrated in <a href="#CD010766-fig-0002">Figure 2</a>. See below for more detailed information on risk of bias. </p> <div class="figure" id="CD010766-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010766-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_n/nCD010766-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010766-sec-0061"> <h4 class="title">Allocation</h4> <p>Participants in the included study (<a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>) were reported to be randomly assigned, but no details were available on sequence generation or allocation concealment. As such, we rated risk of bias in these domains as unclear. </p> </section> <section id="CD010766-sec-0062"> <h4 class="title">Blinding</h4> <p>Participants, caregivers and investigators in the included study were reported to be blinded to the treatment condition; however, it is unclear whether all lab technicians and ADOS evaluators were blinded. It is also uncertain whether parents knew that all children would receive at least one round of oral DMSA during the first phase, and that only high excreters would continue on to the second phase. Knowledge that all children received at least one round of chelation or awareness of who was in the high excreter group would likely yield high risk of bias in the second phase. Therefore, we rated risk of performance bias and risk of detection bias as unclear. </p> </section> <section id="CD010766-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>In phase two, two children (one in each treatment group) withdrew because of perceived lack of benefit, and four children dropped out as the result of adverse effects (two children in the control group for worsening of behaviours, and two children in the experimental group ‐ one for sleep problems and one for worsening of behaviours and skills). Additionally in phase two, one child dropped out as a result of elevated liver enzymes (reported to be due to psychiatric medication) and one child withdrew because of the death of a family member. Trialists did not report if these two children were included in the experimental group or in the control group. We rated risk of attrition bias as low, given that the reason for missing data was deemed unlikely to be related to the true outcome. </p> </section> <section id="CD010766-sec-0064"> <h4 class="title">Selective reporting</h4> <p>The level of urinary excretion of toxic metals was not reported for participants in the control group during or after phase two, and no results were reported with regard to potential differences between the experimental group and the control group in excretion levels of toxic metals during or after phase two. As such, we rated risk of reporting bias as high. </p> </section> <section id="CD010766-sec-0065"> <h4 class="title">Other potential sources of bias</h4> <p>Given that both the experimental group and the control group received an initial round of oral DMSA in phase one, carry‐over effects may have occurred. Trialists acknowledged that the effect of the phase one oral DMSA carried over into phase two: "...the single screening round of DMSA [in phase one] had an unexpectedly dramatic effect on improving abnormal glutathione and platelet levels, and the effect lasted until the end of phase two, so that phase two was not a placebo‐control‐led investigation" (<a href="./references#CD010766-bbs2-0001" title="AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part a ‐ medical results. BMC Pharmacology &amp; Toxicology2009;9(16):1‐22. AdamsJB , BaralM , GeisE , MitchellJ , IngramJ , HensleyA , et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part b ‐ behavioral results. BMC Pharmacology &amp; Toxicology2009;9(17):1‐9. NCT00811083 . Dimercaptosuccinic acid (DMSA) treatment of children with autism and heavy metal toxicity. http://clinicaltrials.gov/show/NCT00811083 (accessed 19 December 2013). ">Adams 2009</a>, p 3). </p> <p>The included study also appears to have biases related to the validity of the statistical conclusions. It is perplexing that the trialists would use an unconventional and atheoretical regression approach without the critical step of including a cross‐validation sample, and given the relatively small sample size and the apparently large set of variables (the number of tested variables was not revealed). Furthermore, use of adjusted R² instead of R² appears to be a less‐than‐satisfactory approach to the handling of sample uniqueness, which likely artificially inflated model effect size. </p> <p>Finally, trialists downplayed the variability of heavy metal levels and the severity of ASD, stating, “Since the toxic metal excretions exhibit considerable correlation amongst themselves, one should refrain from reading too much into the relationships between specific metals and severity of autism" (p 6). This attempt to persuade readers to disregard differences across heavy metals, however, is undermined by the presented regression analyses, which show inconsistencies in the direction of the effects that metal excretion has on various change indices. For example, the unstandardised <i>b</i> ‐weight signs suggest that increased excretion of As9 is associated with differential change patterns in PDD‐BI, ADOS and ATEC scores (although it is unclear how trialists created the change scores). Similar inconsistencies are evident upon examination of Pb9 with PDD‐BI and SAS. Incidentally, trialists did not report the <i>b</i>‐weight for SAS regressed on T19, although they reported on its statistical significance. </p> <p>Given these factors, we rated other bias as high.</p> </section> </section> <section id="CD010766-sec-0066"> <h3 class="title" id="CD010766-sec-0066">Effects of interventions</h3> <p>For the current version of this review, meta‐analysis was not possible, as only one study was included. In the included study, 77 children completed the required blood collection at the beginning of the trial. Of these, 65 children completed phase one, 49 high heavy metal excreters continued to phase two and 41 completed phase two. </p> <section id="CD010766-sec-0067"> <h4 class="title">Primary outcome: social interaction</h4> <section id="CD010766-sec-0068"> <h5 class="title">ATEC sociability subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean (standard deviation (SD)) score on the ATEC sociability subscale decreased from 16.6 (8.5) at the beginning of phase one, to 12.1 (6.5) at the end of phase two. For children in the control group who completed phase two of the trial, the mean (SD) score on the ATEC sociability subscale decreased from 14.9 (6.8) at the beginning of phase one, to 11.2 (6.5) at the end of phase two. The between‐group difference was reported to be non‐significant. </p> </section> <section id="CD010766-sec-0069"> <h5 class="title">PDD‐BI social pragmatic problems subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean (SD) score on the PDD‐BI social pragmatic problems subscale decreased from 16.9 (9.2) at the beginning of phase two, to 14.5 (9.2) at the end of phase two. For children in the control group who completed phase two of the trial, the mean (SD) score on the PDD‐BI social pragmatic problems subscale decreased from 13.9 (7.5) at the beginning of phase two, to 9.9 (7.5) at the end of phase two. The significance of the between‐group difference was not reported. </p> </section> <section id="CD010766-sec-0070"> <h5 class="title">PDD‐BI social approach behaviours subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean (SD) score on the PDD‐BI social approach behaviours subscale increased from 63.8 (20.6) at the beginning of phase two, to 70.8 (23.6) at the end of phase two. For children in the control group who completed phase two of the trial, the mean (SD) score on the PDD‐BI social approach behaviours subscale increased from 68.2 (25.4) at the beginning of phase two, to 72.6 (20.2) at the end of phase two. The significance of the between‐group difference was not reported. </p> </section> <section id="CD010766-sec-0071"> <h5 class="title">ADOS sociability subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean score on the ADOS sociability subscale decreased from 9.3 at the beginning of phase two, to 8.3 at the end of phase two. For children in the control group who completed phase two of the trial, the mean score on the ADOS sociability subscale decreased from 8.1 at the beginning of phase two, to 7.9 at the end of phase two. The between‐group difference was reported to be non‐significant. </p> </section> </section> <section id="CD010766-sec-0072"> <h4 class="title">Primary outcome: communication</h4> <section id="CD010766-sec-0073"> <h5 class="title">ATEC speech/language communication subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean (SD) score on the ATEC speech/language communication subscale decreased from 13.4 (7.7) at the beginning of phase one, to 10.6 (7.0) at the end of phase two. For children in the control group who completed phase two of the trial, the mean (SD) score on the ATEC speech/language communication subscale decreased from 12.0 (8.4) at the beginning of phase one, to 10.5 (8.9) at the end of phase two. The between‐group difference was reported to be non‐significant. </p> </section> <section id="CD010766-sec-0074"> <h5 class="title">ADOS communication subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean score on the ADOS communication subscale decreased from 7.8 at the beginning of phase two, to 7.1 at the end of phase two. For children in the control group who completed phase two of the trial, the mean score on the ADOS communication subscale decreased from 6.7 at the beginning of phase two, to 5.9 at the end of phase two. The between‐group difference was reported to be non‐significant. </p> </section> </section> <section id="CD010766-sec-0075"> <h4 class="title">Primary outcome: stereotypy</h4> <section id="CD010766-sec-0076"> <h5 class="title">PDD‐BI ritualism/resistance to change subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean (SD) score on the PDD‐BI ritualism/resistance to change subscale decreased from 13.9 (10.5) at the beginning of phase two, to 10.0 (7.8) at the end of phase two. For children in the control group who completed phase two of the trial, the mean (SD) score on the PDD‐BI ritualism/resistance to change subscale decreased from 15.0 (8.5) at the beginning of phase two, to 11.5 (8.2) at the end of phase two. The significance of the between‐group difference was not reported. </p> </section> <section id="CD010766-sec-0077"> <h5 class="title">ADOS stereotyped behaviours and restricted interests subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean score on the ADOS stereotyped behaviours and restricted interests subscale decreased from 3.9 at the beginning of phase two, to 3.5 at the end of phase two. For children in the control group who completed phase two of the trial, the mean score on the ADOS stereotyped behaviours and restricted interests subscale was 3.5 at the beginning of phase two and 3.5 at the end of phase two. The between‐group difference was reported to be non‐significant. </p> </section> </section> <section id="CD010766-sec-0078"> <h4 class="title">Primary outcome: adverse events</h4> <p>During phase one, one child experienced an adverse event (lethargy and diminished appetite), causing the child to withdraw from the study (treatment group not specified). During phase two, four children dropped out after experiencing adverse events, including sleep problems (n = 1; experimental group), worsening of behaviours and skills (n = 1; experimental group), increased self stimulatory behaviour (n = 1; control group) and regression of behaviour (n = 1; control group). Two additional children in the experimental group withdrew from the study as the result of low excretion of metals and worsening of symptoms, including sleep problems (n = 1) and sleep problems plus increased tantrums (n = 1). </p> </section> <section id="CD010766-sec-0079"> <h4 class="title">Secondary outcome: aggression</h4> <section id="CD010766-sec-0080"> <h5 class="title">PDD‐BI aggressiveness subscale</h5> <p>For children in the experimental group who completed phase two of the trial, the mean (SD) score on the PDD‐BI aggressiveness subscale decreased from 13.4 (9.8) at the beginning of phase two, to 9.8 (6.7) at the end of phase two. For children in the control group who completed phase two of the trial, the mean (SD) score on the PDD‐BI aggressiveness subscale decreased from 11.4 (8.1) at the beginning of phase two, to 8.4 (7.2) at the end of phase two. The significance of the between‐group difference was not reported. </p> </section> </section> <section id="CD010766-sec-0081"> <h4 class="title">Secondary outcome: heavy metal levels</h4> <p>No results were reported with regard to potential differences between the experimental group and the control group in excretion levels of toxic metals during or after phase two. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010766-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010766-sec-0082"></div> <section id="CD010766-sec-0083"> <h3 class="title" id="CD010766-sec-0083">Summary of main results</h3> <p>Few studies have examined the effectiveness of chelation for ASD, and no true randomised placebo‐controlled trials were identified for this review. This review included only one study, which compared children who received one round of oral dimercaptosuccinic acid (DMSA) versus children who received multiple rounds of oral DMSA, and found no significant differences with regard to autism spectrum disorder (ASD) symptoms. </p> </section> <section id="CD010766-sec-0084"> <h3 class="title" id="CD010766-sec-0084">Overall completeness and applicability of evidence</h3> <p>One trial, which had methodological issues and a relatively small sample size, is insufficient to provide robust evidence on chelation for ASD. The included study compared one round of oral DMSA versus multiple rounds of oral DMSA. Although this study sheds light on the impact of using different quantities of DMSA rounds, it does not address completely the question of whether DMSA is effective in the first place. Moreover, external validity is limited, given that the included study involved children from only one state (Arizona) in the United States of America, and given that only one chelating agent (DMSA) was assessed. Finally, most of the secondary outcomes presented in the protocol of this review (<a href="./references#CD010766-bbs2-0062" title="JamesS , WilliamsK , SiloveN , StevensonSW . Chelation for autism spectrum disorder (ASD). Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD010766] ">James 2013</a>) were not investigated in the included study. </p> </section> <section id="CD010766-sec-0085"> <h3 class="title" id="CD010766-sec-0085">Quality of the evidence</h3> <p>The quality of the evidence is poor. Only one trial was included in this review, and we judged it to have high or uncertain risk of bias and methodological problems that limited the interpretation of outcomes presented. Of particular concern are the trialists’ questionable data analytical approach and interpretation of findings. It is interesting that trialists found differential directions of heavy metal excretion and change in ASD indices, yet they attempted to convince the reader not to read too much into these differences. Given the deleterious effects of chelation, misinterpretation and misuse of the study of Adams et al to justify the use of chelation for ASD is unethical and potentially places children unnecessarily in harm’s way. Moreover, if these findings are in fact valid, they actually undermine the heavy metal toxicity theory and the rationale for chelation treatment, suggesting that it should not be used in the first place. </p> <p>The inclusion of only one study, which had a relatively small sample size and a high likelihood of carry‐over effects and other biases, precludes confidence in the findings. Further well‐designed studies from multiple locations and using larger numbers of participants are needed to better ascertain the effects of chelation for ASD. </p> </section> <section id="CD010766-sec-0086"> <h3 class="title" id="CD010766-sec-0086">Potential biases in the review process</h3> <p>We attempted to minimise bias by having two review authors independently screen studies for inclusion, extract and manage data and assess risk of bias in included studies. Although we attempted to minimise publication bias by using a comprehensive search strategy and by searching multiple sources, we may have failed to identify relevant trials. </p> </section> <section id="CD010766-sec-0087"> <h3 class="title" id="CD010766-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>A systematic review evaluating the effectiveness of chelation for ASD (<a href="./references#CD010766-bbs2-0026" title="DavisTN , O'ReillyM , KangS , LangR , RispoliM , SigafoosJ , et al. Chelation treatment for autism spectrum disorders: a systematic review. Research in Autism Spectrum Disorders2013;7(1):49‐55. ">Davis 2013</a>) was published after the title for this review was registered. The <a href="./references#CD010766-bbs2-0026" title="DavisTN , O'ReillyM , KangS , LangR , RispoliM , SigafoosJ , et al. Chelation treatment for autism spectrum disorders: a systematic review. Research in Autism Spectrum Disorders2013;7(1):49‐55. ">Davis 2013</a> review did not limit inclusion criteria to randomised controlled trials; whereas we included one trial, <a href="./references#CD010766-bbs2-0026" title="DavisTN , O'ReillyM , KangS , LangR , RispoliM , SigafoosJ , et al. Chelation treatment for autism spectrum disorders: a systematic review. Research in Autism Spectrum Disorders2013;7(1):49‐55. ">Davis 2013</a> included five trials. Nonetheless, all of the trials included in the <a href="./references#CD010766-bbs2-0026" title="DavisTN , O'ReillyM , KangS , LangR , RispoliM , SigafoosJ , et al. Chelation treatment for autism spectrum disorders: a systematic review. Research in Autism Spectrum Disorders2013;7(1):49‐55. ">Davis 2013</a> review were reported to have substantial methodological limitations, and the results of our review support the findings reported by <a href="./references#CD010766-bbs2-0026" title="DavisTN , O'ReillyM , KangS , LangR , RispoliM , SigafoosJ , et al. Chelation treatment for autism spectrum disorders: a systematic review. Research in Autism Spectrum Disorders2013;7(1):49‐55. ">Davis 2013</a>; we agree that no available evidence supports the use of chelation to treat individuals with ASD symptoms. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010766-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/urn:x-wiley:14651858:media:CD010766:CD010766-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_t/tCD010766-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010766-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_n/nCD010766-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_n/nCD010766-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010766-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/urn:x-wiley:14651858:media:CD010766:CD010766-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_t/tCD010766-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010766-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_n/nCD010766-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/media/CDSR/CD010766/image_n/nCD010766-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD010766-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Examples of chelating agents</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Name</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Target heavy metals</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Route of administration</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> FDA‐approved indications</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Pharmacokinetics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Pharmacodynamics</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Common adverse effects</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dimercaptosuccinic acid (DMSA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead; arsenic; mercury poisoning</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead poisoning in adults and children &gt; 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tmax 1 to 2 hours;</p> <p>elimination t<sub>1/2</sub> </p> <p>2 hours to 2 days;</p> <p>primarily excreted renally</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forms water‐soluble chelates with heavy metals, which are excreted renally</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rash; gastrointestinal upset</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edetate disodium (EDTA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calcium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intravenous (IV)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypercalcaemia (emergency treatment);</p> <p>digitalis poisoning; ventricular arrhythmia in adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elimination t<sub>1/2</sub> </p> <p>1.4 to 3 hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forms soluble chelate with calcium, resulting in a rapid decrease in plasma calcium concentrations </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue; hypocalcaemia; thrombophlebitis</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sodium 2, 3 dimercaptopropanesulphonate (DMPS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Arsenic; bismuth subcitrate;</p> <p>mercury; Wilson’s disease (copper)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intravenous (IV) and oral</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not approved for use in the United States of America</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elimination t<sub>1/2</sub> 1.8 hours </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Forms water‐soluble chelates with many heavy metals, which are excreted renally</p> <p>High affinity for mercury</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rash;</p> <p>nausea; dysgeusia</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Edetate calcium disodium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lead</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intravenous (IV) and intramuscular (IM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute and chronic lead poisoning;</p> <p>lead encephalopathy in adults and children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Elimination t<sub>1/2</sub> </p> <p>20 to 60 minutes (IV), 1.4 to 3 hours (IM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An effective chelator of extracellular lead, resulting in increased urine excretion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fatigue; nephrotoxicity</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>From <a href="./references#CD010766-bbs2-0054" title="OsterlohJ , BeckerCE . Pharmacokinetics of CaNa2EDTA and chelation of lead in renal failure. Clinical Pharmacology and Therapeutics1986;40(6):686‐93. ">Osterloh 1986</a>; <a href="./references#CD010766-bbs2-0060" title="VamnesJS , EideR , IsrennR , HolPJ , GjerdetNR . Diagnostic value of a chelating agent in patients with symptoms allegedly caused by amalgam fillings. Journal of Dental Research2000;79(3):868‐74. ">Vamnes 2000</a>; <a href="./references#CD010766-bbs2-0028" title="Drugs.com . Drug information online. www.drugs.com/drug‐class/chelating‐agents.html (accessed 10 January 2012). ">Drugs.com 2012</a>. </p> <p>FDA: Food and Drug Administration.<br/> Tmx: time until maximum concentration.<br/> t<sub>1/2</sub>: time until maximum concentration drops in half. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Examples of chelating agents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010766-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Analysis methods planned in our protocol that will be used in updates of this review</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of treatment effect</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will analyse dichotomous outcomes by calculating the risk ratio (RR) and the corresponding 95% confidence interval (CI). For continuous data, we will calculate mean difference (MD) and corresponding 95% CI if studies used the same rating scales. As recommended by <a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>, we will focus on final values unless change scores are used in some of the studies. We will combine in the same meta‐analysis studies that reported final values with studies that reported only change scores, provided the studies used the same rating scale (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). A potential problem associated with including change scores is that the standard deviation of changes may not be reported in the original study (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We will contact trial authors and will attempt to estimate the standard deviation of changes if not reported. We will calculate the standardised mean difference (SMD) with 95% CIs if studies used different scales to measure the same outcomes </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Multiple outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If studies provided multiple, interchangeable measures of the same construct at the same point in time, we will calculate the average SMD across outcomes and the average estimated variances (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis issues</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>When possible, we will obtain mean treatment differences and standard errors for cross‐over trials, and will enter these into RevMan under the generic inverse variance outcome type (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We will create a single pair‐wise comparison for each identified multi‐arm study by combining all relevant experimental groups into a single group, and by combining all relevant control groups into a single group (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dealing with missing data</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will attempt to contact trial investigators to request missing data. If missing data are provided by the trialists, we will conduct meta‐analysis according to intention‐to‐treat principles using all data and keeping participants in the treatment group to which they were originally randomly assigned, regardless of the treatment that they actually received (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If missing data are not provided, we will analyse only available data, and we will not impute missing data given that symptoms of autism spectrum disorder (ASD) vary greatly. We will document missing data and attrition in the ’Risk of bias’ table, and we will discuss how missing data may affect interpretation of the results </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of heterogeneity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will assess clinical heterogeneity by comparing the between‐trials distribution of participant characteristics (e.g. children vs adults), trial characteristics (e.g. cross‐over vs parallel design) and intervention characteristics (e.g. treatment type, dose). We will evaluate statistical heterogeneity using the I² statistic and the Chi² test of heterogeneity, with statistical significance set at P value &lt; 0.10. We will consider I² values as follows. </p> <p> <ol id="CD010766-list-0015"> <li> <p>0% to 29% might not be important</p> </li> <li> <p>30% to 49% may represent moderate heterogeneity</p> </li> <li> <p>50% to 74% may represent substantial heterogeneity</p> </li> <li> <p>75% to 100% represents considerable heterogeneity (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of reporting biases</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If 10 or more studies are found, we will use funnel plots to investigate the relationship between intervention effect and study size. Asymmetry of a funnel plot may indicate, among other things, publication bias or poor methodological quality (<a href="./references#CD010766-bbs2-0029" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). We will explore possible reasons for any asymmetry found </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Data synthesis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will synthesise results in a meta‐analysis using a fixed‐effect model when studies are similar enough with regard to the intervention, population and methods to assume that the same treatment effect is estimated. We will synthesise results in a meta‐analysis using a random‐effects model when statistical heterogeneity is found, or when studies differ enough with regard to the intervention, population and methods to assume that different yet related treatment effects are estimated, and when it is deemed to be clinically relevant (<a href="./references#CD010766-bbs2-0042" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct the following subgroup analyses</p> <p> <ol id="CD010766-list-0016"> <li> <p>Type of ASD (e.g. autistic disorder vs Asperger’s disorder)</p> </li> <li> <p>Participant age (e.g. adult vs child, preschool vs school‐age)</p> </li> <li> <p>Treatment type (e.g. dimercaptosuccinic acid (DMSA) vs other agents)</p> </li> <li> <p>Treatment dosage (e.g. DMSA dose of 10 mg/kg body weight administered 3 times per day vs higher doses) </p> </li> <li> <p>Length of follow‐up (e.g. ≤ 3 months vs &gt; 3 months)</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct sensitivity analyses to investigate the effect on overall results of excluding trials when </p> <p> <ol id="CD010766-list-0017"> <li> <p>Allocation concealment or sequence generation was inadequate (selection bias)</p> </li> <li> <p>Blinding was not done (performance bias)</p> </li> <li> <p>Outcome data were incomplete (attrition bias)</p> </li> </ol> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Analysis methods planned in our protocol that will be used in updates of this review</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010766.pub2/full#CD010766-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010766.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010766-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010766-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010766-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010766-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD010766-note-0002">日本語</a> </li> <li class="section-language"> <a class="" href="pl#CD010766-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD010766-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010766\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010766\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010766\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010766\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010766\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010766.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010766.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010766.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010766.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010766.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720138601"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010766.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720138604"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010766.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df9d98c869377',t:'MTc0MDcyMDEzOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 